Safety and Tolerability Study of Voreloxin and Cytarabine Combination in Acute Myeloid Leukemia in Humans
Status:
Completed
Trial end date:
2012-02-15
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and tolerability of voreloxin (vosaroxin) injection in
combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia.